These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8036081)

  • 1. Multi-organ disease secondary to sulfonamide toxicity.
    Pickert CB; Belsha CW; Kearns GL
    Pediatrics; 1994 Aug; 94(2 Pt 1):237-9. PubMed ID: 8036081
    [No Abstract]   [Full Text] [Related]  

  • 2. Is co-trimoxazole safe?
    Jick H; Derby LE
    Lancet; 1995 Apr; 345(8957):1118-9. PubMed ID: 7715367
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse reactions to trimethoprim-sulfamethoxazole.
    Lawson DH; Paice BJ
    Rev Infect Dis; 1982; 4(2):429-33. PubMed ID: 7051241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity.
    Jick H; Derby LE
    Pharmacotherapy; 1995; 15(4):428-32. PubMed ID: 7479194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are chemically reactive metabolites responsible for adverse reactions to drugs?
    Williams DP; Kitteringham NR; Naisbitt DJ; Pirmohamed M; Smith DA; Park BK
    Curr Drug Metab; 2002 Aug; 3(4):351-66. PubMed ID: 12093355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical problem-solving. We blew it.
    Kreisberg R
    N Engl J Med; 1995 Apr; 332(14):945-9. PubMed ID: 7661934
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim.
    Alberti-Flor JJ; Hernandez ME; Ferrer JP; Howell S; Jeffers L
    Am J Gastroenterol; 1989 Dec; 84(12):1577-9. PubMed ID: 2596461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical review of the literature on carbon disulfide toxicity.
    Beauchamp RO; Bus JS; Popp JA; Boreiko CJ; Goldberg L
    Crit Rev Toxicol; 1983; 11(3):169-278. PubMed ID: 6349939
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoprophylaxis with oral trimethoprim-sulfamethoxazole. In otitis media. Relevance of hematologic abnormalities.
    Cunningham MJ
    Clin Pediatr (Phila); 1990 May; 29(5):273-7. PubMed ID: 2187645
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nonsteroidal anti-inflammatory agents in pediatrics (2)].
    Louis JJ
    Pediatrie; 1984 Jun; 39(4):295-313. PubMed ID: 6390335
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicity of inorganic arsenic salts.
    Winship KA
    Adverse Drug React Acute Poisoning Rev; 1984; 3(3):129-60. PubMed ID: 6397979
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse effects of antimicrobial drugs.
    Yusuf SM
    J Pak Med Assoc; 1976 Nov; 26(11):226-9. PubMed ID: 829150
    [No Abstract]   [Full Text] [Related]  

  • 13. Undesired effects of the sulphonylurea drugs.
    Paice BJ; Paterson KR; Lawson DH
    Adverse Drug React Acute Poisoning Rev; 1985; 4(1):23-36. PubMed ID: 3890480
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe liver injuries due to sulfamethoxazole-trimethoprim and sulfamethoxydiazine.
    Horák J; Mertl L; Hrabal P
    Hepatogastroenterology; 1984 Oct; 31(5):199-200. PubMed ID: 6510880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon disulfide poisoning: a review.
    Davidson M; Feinleib M
    Am Heart J; 1972 Jan; 83(1):100-14. PubMed ID: 4334674
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of halogenated anesthetics on the liver, thyroid gland and kidney].
    Lebeau R
    Union Med Can; 1970 Apr; 99(4):684-6. PubMed ID: 5511493
    [No Abstract]   [Full Text] [Related]  

  • 17. Hospitalization for serious blood and skin disorders following co-trimoxazole.
    Myers MW; Jick H
    Br J Clin Pharmacol; 1997 Jun; 43(6):649-51. PubMed ID: 9205827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic, cutaneous and hematologic manifestations in juvenile chronic arthritis.
    Barash J; Cooper M; Tauber Z
    Clin Exp Rheumatol; 1991; 9(5):541-3. PubMed ID: 1954707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor administration: adverse events.
    D'Souza A; Jaiyesimi I; Trainor L; Venuturumili P
    Transfus Med Rev; 2008 Oct; 22(4):280-90. PubMed ID: 18848155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced hemophagocytosis.
    Lambotte O; Costedoat-Chalumeau N; Amoura Z; Piette JC; Cacoub P
    Am J Med; 2002 May; 112(7):592-3. PubMed ID: 12015259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.